Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Orchard Therapeutics and MolMed have extended their collaboration – initiated in April 2018 – for a period of five years through June 2025.
read more
Lonza announced the establishment of a Center of Excellence for Dry Powder Inhaler drug product development at its OR site.
read more
Vetter and Rentschler Biopharma have announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.
read more
Artelo Biosciences has expanded its existing research and worldwide commercial license agreement with The Research Foundation For The State University of New York, Stony Brook.
read more
Catalent has signed an agreement with ViralClear to work on the development of a potential treatment for adults with advanced COVID-19.
read more
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform.
read more
Piramal has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Cascade Chemistry has been selected to produce the active pharmaceutical ingredient (API) for clinical trial supplies of RBT-9.
read more
Novadoz has received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.
read more
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19.
read more
AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialize therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of cancer.
read more
The PolyPeptide Group has partnered with Novavax on large-scale GMP production of a critical component of Novavax’ novel coronavirus vaccine candidate, NVX-CoV2373.
read more
Jounce Therapeutics has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb.
read more
Celerion has announced the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America.
read more
Mylan and Lupin announced that the EC has granted marketing authorization for Nepexto, a biosimilar to Enbrel.
read more